Study of Weekly RG-012 Injections in Patients With Alport Syndrome

Condition:   Alport Syndrome Interventions:   Drug: RG-012;   Drug: Placebo Sponsor:   Regulus Therapeutics Inc. Not yet recruiting - verified August 2016

Source: ClinicalTrials.gov - July 28, 2016 Category: Research Source Type: clinical trials